Results from the Oxford/AstraZeneca phase 3 vaccine trial are expected by the end of the month. Hopes are high following the announcement that a second vaccine, developed by Moderna, appears to be 95% effective. The findings come just a week after Pfizer released similarly impressive data. The good news keeps on coming.
Labour to win landslide victory, says new poll
According to the findings, the Tories could be left with a puny 129 seats in next year’s general election.